MARY BURKHART-GORDON: Open Payments
NPI 1821169590 · COLORADO SPRINGS, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,658 in 77 payments from 16 companies in 2025. Trend: 2023 $260 · 2024 $0 · 2025 $1,658
Food & beverage: $1,658
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 28 | $469 |
| UCB, Inc. | 11 | $404 |
| ABBVIE INC. | 11 | $233 |
| Novartis Pharmaceuticals Corporation | 5 | $86 |
| Mallinckrodt Hospital Products Inc. | 4 | $63 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Alexion Pharmaceuticals, Inc. | 2 | $52 |
| Organon LLC | 2 | $48 |
| Lilly USA, LLC | 2 | $48 |
| ANI Pharmaceuticals, Inc. | 2 | $47 |
Products named: Bimzelx, RINVOQ, OTEZLA, KRYSTEXXA, EVENITY, ACTHAR, TAVNEOS, BENLYSTA.
Industry payments across CO — which companies pay providers there.
